0 new0 added0 reduced29 sold outnet sold ≈ $1.8m (-1.9m shares)
* Summed across managers. Shares that two managers' reports both contain – a
subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are
counted once.
Holder counts are more reliable.
Trends to Q2 2026
Institutional holders
Managers reporting a position, each quarter
Numbers
Quarter
Holders
Q3 2022
48
Q4 2022
48
Q1 2023
39
Q2 2023
37
Q3 2023
38
Q4 2023
42
Q1 2024
38
Q2 2024
41
Q3 2024
36
Q4 2024
37
Q1 2025
31
Q2 2025
29
Q3 2025
29
Q4 2025
31
Q1 2026
29
Q2 2026
0
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D
if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the
stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder
worked them out.
Holder
Stake
Change
Shares
Last filed
BED BATH & BEYOND, INC.
13D · may seek influenceno change · filed 2025-09-17Stated purposeItem 4 of the Schedule 13D is hereby amended and supplemented as follows:
On September 15, 2025, the Reporting Person and the Issuer entered into Amendment No. 1 to the Amended and Restated Term Loan Credit Agreement ("Amendment No. 1 to the A&R Credit Agreement"), pursuant to which the Reporting Person agreed provide new delayed-draw term loan commitments in an aggregate original principal amount of $20 million, with such debt evidenced by notes (the "Delayed Draw Notes") convertible into shares of the Issuer's Common Stock in accordance with the terms of the A&R Credit Agreement, as amended. The Delayed Draw Notes can be converted into Common Stock at a price determined at the time of such conversion election, but subject to Nasdaq shareholder approval rules, if applicable.
The f…
Full filing